13.35
0.00
(0.00%)
At close: February 25 at 1:19:14 PM CST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
64,547
108,632
105,761
27,376
Total Liabilities Net Minority Interest
23,983
34,651
9,943
5,826
Total Equity Gross Minority Interest
40,564
73,981
95,818
21,550
Total Capitalization
43,364
76,270
97,530
23,373
Preferred Stock Equity
1
1
1
--
Common Stock Equity
40,563
73,980
95,817
21,550
Capital Lease Obligations
4,141
4,085
1,594
433
Net Tangible Assets
40,564
73,981
95,818
21,550
Working Capital
25,882
69,961
95,646
22,264
Invested Capital
43,363
76,269
97,529
23,607
Tangible Book Value
40,563
73,980
95,817
21,550
Total Debt
6,941
6,374
3,306
2,490
Share Issued
256,688.30
221,721.18
199,502.18
184,133.38
Ordinary Shares Number
256,566.80
221,599.68
199,380.68
184,011.88
Treasury Shares Number
121.50
121.50
121.50
121.50
12/31/2020 - 6/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INO.MX Inovio Pharmaceuticals, Inc.
40.00
0.00%
ATOS.MX Atossa Therapeutics, Inc.
14.70
-8.13%
NRSNW NeuroSense Therapeutics Ltd.
0.1531
-23.45%
MRNA.MX Moderna, Inc.
624.80
+0.29%
ENTO Entero Therapeutics, Inc.
0.6100
+23.31%
NRSN NeuroSense Therapeutics Ltd.
1.0500
-4.11%
ITRM Iterum Therapeutics plc
1.3300
-4.66%
ATOS Atossa Therapeutics, Inc.
0.7410
-3.23%
SLS SELLAS Life Sciences Group, Inc.
1.1600
-1.69%
INO Inovio Pharmaceuticals, Inc.
1.8400
-7.07%